Volume 16 - Issue 5 - May 2003
Diabetes Watch »
Last month, Medicare began reimbursing for hyperbaric oxygen (HBO) treatment as an adjunctive therapy for diabetic foot ulcers. After an exhaustive review of the literature, the Centers for Medicare and Medicaid (CMS) concluded that “HBO therapy is clinically effective and, thus, reasonable and necessary in the treatment of certain patients with limb-threatening diabetic wounds of the lower extremity.”
According to the CMS, patients must meet each of the following three criteria:
• the patient has type I or type II diabetes and has a lower extremity wound that is due to diabetes;
Diagnostic Dilemmas »
There is a great deal of satisfaction when our diabetic foot care team gets referrals for patients who were previously seen by doctors from surrounding regions and other nations. However, there is also a great deal of difficulty with poorly or improperly managed cases. In this diagnostic dilemma, I’d like to focus on one patient who was sent to us after one year of care by several doctors.
The patient in question is a 70-year-old male, who was previously seen by two podiatrists and an orthopedist. His initial complaint was a small blister plantar to the first metatarsal head of his left f
Editor's Perspective »
Would I want justice if I underwent an amputation procedure that was later deemed to be unnecessary? You bet. Do I think this kind of clinical situation happens on a routine basis? Hardly. However, you wouldn’t know it by the seemingly skyrocketing malpractice insurance premiums being reported across the country.
Escalating jury verdicts seem to play a big role. A July 2002 report from the U.S. Department of Health and Human Services (HHS) noted there was a 76 percent increase in the average jury malpractice award from 1996 to 1999. You have to wonder how many verdicts are being fueled m
I am occasionally asked why I write this column. The answer is simple. Writing fulfills my need to engage in an activity where if I screw up and make mistakes, there are no dire consequences and nobody gets hurt. At times, I overstate an opinion and a fellow DPM gets mad but that doesn’t count.
There are aspects of my life in which it is more imperative to avoid mistakes. I’m a husband and father. I’m a doctor. I’m an instrument rated pilot. If I make mistakes in these roles, people can get hurt. I am responsible not to let mistakes occur and to pay the consequences if they do.
New Products »
When treating those who suffer from athlete’s foot, you may want to consider a new lotion that combines two ingredients to offer relief.
The topical lotion deFEET® uses the advanced transdermal drug delivery system of PENtoCORE, which facilitates deeper penetration of the active ingredient of tolnaftate.
BioChemics, the manufacturer of the product, says deFEET relieves athlete’s foot infection and itchy, scaly, burning feet.
In fact, a clinical trial at the New England Medical Center showed that deFEET cured 100 percent of patients in 10 days, according to the
News and Trends »
Is total contact casting (TCC) too time-consuming a modality to be used in treating plantar foot ulcerations? It’s a prevailing question that has thwarted wider use of the modality. However, a new study recently presented at the Symposium on Advanced Wound Care (SAWC) attempts to shed new light on the “time-effectiveness” of TCC.
Study researchers concede there is a “relatively low use rate” of total contact casts for diabetic foot ulcers. Why? They say many do not use TCC because of the time involved in the process and frequent office visits. However, previous studies have shown th
- « Previous
- | Page 1 of 3 |
- Next »